Patent 7785791 was granted and assigned to Genentech on August, 2010 by the United States Patent and Trademark Office.
The present invention concerns polypeptides comprising a variant Fc region. More particularly, the present invention concerns Fc region-containing polypeptides that have altered effector function as a consequence of one or more amino acid modifications in the Fc region thereof.